Related Experiment Video

Updated: Dec 24, 2025

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

3.1K

MicroRNA-488 inhibits ovarian cancer cell metastasis through regulating CCNG1 and p53 expression

J-Y Guo1, X-Q Wang, L-F Sun

  • 1Department of Obstetrics and Gynecology, Beijing Jishuitan Hospital, Beijing, China. 454366711@qq.com.

European Review for Medical and Pharmacological Sciences
|April 10, 2020
PubMed
Abstract

Insights

MicroRNA-488 (miR-488) acts as a tumor suppressor in ovarian cancer (OC) by inhibiting metastasis. Reduced miR-488 expression correlates with poor prognosis, highlighting its diagnostic and therapeutic potential in OC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • MicroRNAs (miRNAs) are crucial regulators in cancer, offering potential breakthroughs in diagnosis and treatment.
  • Ovarian cancer (OC) remains a significant health challenge, necessitating novel therapeutic targets.
  • Understanding specific miRNA roles, like microRNA-488 (miR-488), in OC is vital.

Purpose of the Study:

  • To investigate the regulatory mechanism of miR-488 in ovarian cancer.
  • To determine the relationship between miR-488 expression and clinical outcomes in OC patients.
  • To elucidate the role of miR-488 in OC cell metastasis and its molecular targets.

Main Methods:

  • Quantitative Real Time-Polymerase Chain Reaction (qRT-PCR) and Western blot assays were used to measure miR-488 and CCNG1 expression.
  • Transwell assays and epithelial-mesenchymal transition (EMT) markers assessed the impact of miR-488 on cell metastasis.
  • Dual-luciferase reporter assays confirmed the direct targeting of CCNG1 by miR-488.

Main Results:

  • miR-488 expression was significantly reduced in OC tissues and associated with poor patient prognosis.
  • miR-488 inhibited OC cell metastasis by suppressing EMT and enhancing tumor suppressor p53 expression.
  • CCNG1 was identified as a direct target of miR-488, and its upregulation counteracted miR-488's inhibitory effects.

Conclusions:

  • miR-488 functions as a tumor suppressor in OC by inhibiting cell metastasis.
  • The findings suggest miR-488 holds significant potential for the diagnosis and treatment of ovarian cancer.
  • Targeting miR-488 or its downstream pathways could offer novel therapeutic strategies for OC.

More Related Videos

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.7K
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

7.9K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.6K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.2K